June 3, 2013
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) and the University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center today announced the formation of the Oncology Innovation Alliance (OIA), a public-private partnership focusing on the discovery and development of novel therapies and their potential role in treating various types of hematologic cancers and solid tumors.
May 30, 2013
Should anyone doubt America’s mounting health crisis, a new report from the National Research Council and Institute of Medicine makes it crystal clear. On average, Americans of all ages die sooner and experience higher rates of disease than people in 16 other rich countries.
May 16, 2013
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory.
May 10, 2013
The UCSF Helen Diller Family Comprehensive Cancer Program’s Breast Oncology Program (BOP) has been selected as a beneficiary of the Tri-Valley SOCKs (Stepping Out for Cancer Kures) 2013 Bras for the Cause Walk.
May 8, 2013
A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.
May 7, 2013
A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UC San Francisco researchers have found.
May 1, 2013
More than 150 of the nation’s top innovators will convene Thursday and Friday in a summit at UC San Francisco that aims to leverage science and technology to transform health and medicine as we know it.
April 30, 2013
UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, joined Francis Collins, MD, PhD, director of the National Institutes of Health, and Peggy Hamburg, MD, commissioner of the Food and Drug Administration, to talk about precision medicine in the lead up to the OME Precision Medicine Summit at UCSF.
April 29, 2013
Surgery is often recommended for skin cancers, but older, sicker patients can endure complications as a result and may not live long enough to benefit from the treatment.
April 24, 2013
Three UC San Francisco scientists have been selected to join the 2013 class of one of the nation’s most prestigious honorary societies for top scholars, scientists, writers, artists and civic, corporate, and philanthropic leaders.